share_log

Invivyd | 4: Statement of changes in beneficial ownership of securities-10% Owner Adimab, LLC

Invivyd | 4：持股變動聲明-股東 Adimab, LLC

美股sec公告 ·  01/22 00:00
Moomoo AI 已提取核心訊息
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Adimab, LLC completed a sale of 5,000,000 shares of Invivyd, Inc. (IVVD) common stock on January 19, 2024. The shares were sold at a price of $3.95 per share, resulting in a total transaction value of $19,750,000. Following the transaction, Adimab, LLC's direct holdings in Invivyd amount to 21,687,906 shares. The sale was conducted in the open market.
Adimab, LLC於2024年1月19日完成了對Invivyd, Inc.（IVVD）500萬股普通股的出售。這些股票以每股3.95美元的價格出售，總交易額爲19,750,000美元。交易完成後，Adimab, LLC在Invivyd的直接持股量爲21,687,906股。此次出售是在公開市場上進行的。
Adimab, LLC於2024年1月19日完成了對Invivyd, Inc.（IVVD）500萬股普通股的出售。這些股票以每股3.95美元的價格出售，總交易額爲19,750,000美元。交易完成後，Adimab, LLC在Invivyd的直接持股量爲21,687,906股。此次出售是在公開市場上進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息